Frequency distribution of C3435T mutation in exon 26 of the MDR1 gene in a Spanish population

Therapeutic Drug Monitoring

Volumn 25, Issue 1, 2003, Pages 107-111

  Bernal, Maria Luisa ^a,b   Sinues, Blanca ^a   Fanlo, Ana ^a   Mayayo, Esteban ^a  

^a UNIVERSITY OF ZARAGOZA   (Spain)

^b UNIVERSITY OF ZARAGOZA   (Spain)

Author keywords

MDR1 gene; P glycoprotein; Spanish population frequency

Indexed keywords

GENE PRODUCT; GLYCOPROTEIN P; MULTIDRUG RESISTANCE PROTEIN 1;

ADULT; AFRICA; AGED; ALLELISM; ARTICLE; ASIA; CORRELATION ANALYSIS; DNA DETERMINATION; DRUG TRANSPORT; DRUG UPTAKE; EXON; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC TRAIT; GENOTYPE; GERMANY; HOMOZYGOSITY; HUMAN; MALE; MULTIDRUG RESISTANCE; NORMAL HUMAN; POLYMERASE CHAIN REACTION; PORTUGAL; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SPAIN; UNITED KINGDOM;

ADOLESCENT; ADULT; AGED; CONFIDENCE INTERVALS; CYTOSINE; EXONS; GENE FREQUENCY; GENES, MDR; HUMANS; MIDDLE AGED; MUTATION; POLYMORPHISM, GENETIC; SPAIN; THYMINE;

EID: 0037307357     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007691-200302000-00016     Document Type: Article

References (29)

1. Gottesman MM, Pastan I, Ambdukar A. P-glycoprotein and multidrug resistance. Curr Opin Genet Dev 1996;6:610-7.
2. Chen CJ, Clark DP, Ueda K, et al. Genomic organization of the human multidrug resistance (MDR1) gene and origin of P-glycoproteins. J Biol Chem 1990;265:506-14.
3. Goldstein LJ, Galski H, Fojo A. Expression of a multidrug resistance gene in human cancers. J Natl Cancer Inst 1989;2:116-24.
4. Ambudkar SV, Dey S, Hrycyna CA, et al. Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annu Rev Pharmacol Toxicol 1999;39:361-98.
5. Greiner B, Eichelbaum M, Fritz P, et al. The role of intestinal P-glycoprotein in the interaction of digoxin and rifampicin. J Clin Invest 1999;104:147-53.
6. Low KS, Mayo RR, Leichtman AB, et al. Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine. Clin Pharmacol Ther 1997;62:248-60.
7. Kaplan B, Low K, Craig R, et al. Low bioavailability of cyclosporine microemulsion and tacrolimus in a small bowel transplant recipient: possible relationship to intestinal P-glycoprotein activity. Transplantation 1999;67:333-5.
8. Lee JS, Paull K, Alvarez M, et al. Rhodamin efflux patterns predict P-glycoprotein substrates in the national cancer institute drug screen. Mol Pharmacol 1994;46:627-38.
9. Schinkel AH, Wagenaar E, Mol CA, et al. P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs. J Clin Invest 1996;97:2517-24.
10. Tanigawara Y. Role of P-glycoprotein in drug disposition. Ther Drug Monit 2000;22:137-40.
11. Hoffmeyer S, Burk O, von Richter O, et al. Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc Natl Acad Sci U S A 2000;97:3474-8.
12. Cascorbi I, Gerloff T, Thomas MD, et al. Frequency of single nucleotide polymorphism in the P-glycoprotein drug transporter MDR1 gene in white subjects. Clin Pharmacol Ther 2001;69:169-74.
13. Delph Y. TAG basic science report, 2000.
14. Hitzl M, Drescher S, van der Kuip H, et al. The C3435T mutation in the human MDR1 gene is associated with altered efflux of the P-glycoprotein substrate rhodamine 123 from CD56+ natural killer cells. Pharmacogenetics 2001;11:293-8.
15. Ameyaw MM, Regateiro F, Li T, et al. MDR1 pharmacogenetics: frequency of the C3435T mutation in exon 26 is significantly influenced by ethnicity. Pharmacogenetics 2001;11:217-21.
16. Sachse C, Brockmöller J, Baurer S, et al. Cytochrome P450 2D6 variants in a Caucasian population: allele frequencies and phenotypic consequences. Am J Hum Genet 1997;60:284-95.
17. Agundez JAG, Martinez C, Ledesma MC, et al. Genetic basis for differences in debrisoquin polymorphism between a Spanish and other white populations. Clin Pharmacol Ther 1994;55:412-7.
18. Bernal ML, Sinues B, Johansson I, et al. Ten percent of North Spanish subjects carry duplicated or triplicated CYP2D6 genes associated with ultrarapid metabolism of debrisoquine. Pharmacogenetics 1999;9:657-60.
19. Neitzel HA. A routine method for the establishment of permanent growing lymphoblastoid cell lines. Hum Genet 1986:73:320-32.
20. Holloway M, Yam P. Reflecting differences. Health care begins to address needs of women and minorities. Sci Am 1992;266:10-2.
21. Clifford R, Edmonson M, Hu Y, et al. Expression-based genetic/physical maps of single-nucleotide polymorphisms identified by the cancer genome anatomy project. Genome Res 2000;10:1259-65.
22. Olden K, Guthrie J. Genomics: implications for toxicology. Mutat Res 2001;473:3-10.
23. Min DL, Lee M, Ku YM, et al. Gender-dependent racial difference in disposition of cyclosporine among healthy African American and white volunteers. Clin Pharmacol Ther 2000;68:478-86.
24. Scheaffeler E, Eichelbaum M, Brinkmann U, et al. Frequency of C3435T polymorphism of MDR1 gene in African people. Lancet 2001;358:383-4.
25. Tanabe M, Ieri I, Nagata N, et al. Expression of P-glycoprotein in human placenta: relation to genetic polymorphism of the multidrug resistance (MDR)-1 gene. J Pharmacol Exp Ther 2001;297:1137-43.
26. Sparreboom A, van Asperen J, Mayer U, et al. Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine. Proc Natl Acad Sci U S A 1997;94:2031-5.
27. Schinkel AH, Mol CA, Wagenaar E, et al. Multidrug resistance and the role of P-glycoprotein knockout mice. Eur J Cancer 1995;31A:1295-8.
28. Hashida T, Masuda S, Uemoto S, et al. Pharmacokinetics and prognostic significance of intestinal MDR1 expression in recipients of living-donor liver transplantation. Clin Pharmacol Ther 2001;69:308-16.
29. Wacher VJ, Wu Y, Benet LZ. Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P-glycoprotein: implications for drug delivery and activity in cancer chemotherapy. Mol Carcinog 1995;13:129-34.